XY028-133 |
رقم الكتالوجGC62701 |
XY028-133 (المثال 14) عبارة عن جهاز CDK4 / 6 قائم على PROTAC مع نشاط مضاد للورم ، والذي يتكون من روابط لـ von Hippel-Lindau و CDK
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2229974-73-4
Sample solution is provided at 25 µL, 10mM.
XY028-133 (example 14) is a PROTAC-based CDK4/6 degrader with anti-tumor activity[1].
XY028-133 (1 and 3 μM, 24 h) significantly decreases CDK4/6, Cyclin A, PLK1 and pRb protein levels in A375 cells[1].
[1]. JIN, Jian, et al. COMPOSITIONS AND METHODS FOR TREATING CDK4/6-MEDIATED CANCER. Patent. US2017/065027.
Average Rating: 5
(Based on Reviews and 20 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *